home / stock / srne / srne news


SRNE News and Press, Sorrento Therapeutics Inc. From 09/16/20

Stock Information

Company Name: Sorrento Therapeutics Inc.
Stock Symbol: SRNE
Market: NASDAQ
Website: sorrentotherapeutics.com

Menu

SRNE SRNE Quote SRNE Short SRNE News SRNE Articles SRNE Message Board
Get SRNE Alerts

News, Short Squeeze, Breakout and More Instantly...

SRNE - What Are The Best Biotech Stocks To Watch Before Friday? 3 To Know

Looking For Top Biotech Stocks To Watch This Week? Investors seeking out high growth in their investments will often turn to biotech stocks . The boom in the biotechnology industry in recent decades built on the increasing understanding we have on biology. For this reason, investors have been...

SRNE - Monoclonal Antibodies: A Good Place To Be In The Time Of Covid-19 And Stock Market Bubbles

Japanese High In 1989, the Japanese Nikkei hit 38,916. It was a time of craziness. The Emperor's palace was valued at equal to all of the real estate in California. Such prices are unsustainable. The Nikkei 30 years out sits at 23,205. Someday, the high point of the Nikkei will be surpassed,...

SRNE - Why Psychedelic Medicine Startups Are Poised To Get A Share Of Next Billion Dollar Market

September 15, 2020 Palm Beach, FL – September 15, 2020 – Investors are seeing big opportunity in psychedelics based upon the numbers that the nascent cannabis industry has been putting up… after all, last year, worldwide sales of legal cannabis re-accelerated ...

SRNE - NVDA, ORCL among premarket gainers

Immunomedics (NASDAQ: IMMU )   +106%  after Gilead to buy the company for $21B (~$88/share). More news on: Immunomedics, Inc., Cassava Sciences, Inc., China Natural Resources, Inc., , Stocks on the move, Read more ...

SRNE - Sorrento in-licenses next-gen antibody-drug conjugate technology from Mayo Clinic

Sorrento Therapeutics (NASDAQ: SRNE ) inks an agreement with Mayo Clinic securing exclusive rights to a technology platform that, it says, is capable of generating a great diversity of stable antibody-drug-nanoparticle albumin-bound (nab) immune complexes (ADNICs) targeting many types of...

SRNE - Sorrento Secures Exclusive License From Mayo Clinic for Antibody-Drug-Nanoparticle Albumin-Bound Immune Complex (ADNIC) Platform

SAN DIEGO, Sept. 14, 2020 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento") today announced it has entered into an exclusive license agreement with Mayo Clinic for a potential breakthrough technology platform that is capable of generating a great diversity of stable...

SRNE - 2 Biotech Stocks with Jaw-Dropping Growth Potential

Biotech stocks have proven time and again to be outstanding growth vehicles for risk-tolerant investors. Underscoring this point, companies like Axsome Therapeutics , Immunomedics , and Novavax have each generated enormous returns on capital for investors within an exceedingly short period o...

SRNE - Will Robinhood Investors Regret Going All In on Coronavirus Stocks?

Investors using the Robinhood online trading platform love healthcare stocks these days -- but not just any healthcare stocks. A look at the most popular stocks on the platform shows us that Robinhood investors are favoring companies developing vaccines or treatments for COVID-19, the illne...

SRNE - Got $3,000? These 4 Emerging Coronavirus Vaccine Stocks Look Like a Bargain

A coronavirus vaccine would arguably save countless lives and help economies around the world recover from a recession through herd immunity. As a result, everyone in the investment world is talking about biotechs that are scrambling to develop a vaccine against SARS-CoV-2, the coronavirus that...

SRNE - Sorrento Therapeutics (SRNE) Investor Presentation - Slideshow

The following slide deck was published by Sorrento Therapeutics, Inc. in conjunction with this Read more ...

Previous 10 Next 10